SERPINA3 and focal segmental glomerulosclerosis: SerpinA3 has been described to have anti-inflammatory properties8–12,26,28, therefore, we decided to evaluate uSerpinA3 in AAV, a severe renal inflammatory disease, and compared it to FSGS patients, a proteinuric but less inflammatory disease.